Rumors of a takeover offer by Sanofi-Aventis SA sent shares of Genzyme Corp. up 15.4 percent Friday, only days after the Cambridge, Mass.-based biotech reported that it was finally getting back on track following last year's manufacturing debacle. (BioWorld Today)